NCT01371656
Clinical Trial Information
Trial Number: NCT01371656 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Miscellaneous
Trial Title:
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Study ID:
ACCL0934
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01371656-D6 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D6 provides the information for chemotherapy groups (eTable 2). Data provided for all eligible Acute Myeloid or Acute Lymphoblastic Leukemia patients (N=381 entries or 198 patients). The number of rows per patient is dependent on number of chemotherapy cycles submitted. |
| NCT01371656-D5 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D5 provides the information for susceptibility test results described in the manuscript (text only). Data limited to evaluable patients with susceptibility tests (N=136 entries). There are multiple rows per patient. |
| NCT01371656-D4 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D4 provides the information for adverse events or serious adverse events during the infection observation period. Data limited to all evaluable patients with adverse events or serious adverse events (N=176 entries). The number of rows per patient is dependent on number of adverse events submitted. |
| NCT01371656-D3 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D3 provides the musculoskeletal (MSK) information as reported in the manuscript (Table 3). Data limited to all evaluable patients with MSK data (N=1318 entries). There are multiple rows per patient. |
| NCT01371656-D2 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D2 provides the information for baseline characteristics and all primary, secondary and post-hoc analyses as reported in the manuscript (Tables 1-5). Additionally, information regarding conditioning, GVHD prophylaxis and serotherapy as reported in the supplemental table of the manuscript can be found here as well (eTable 2). Data provided for all eligible patients (N=617) but the analysis is limited to all evaluable patients (N=613, INEVAL≠1). There is one row per patient. |
| NCT01371656-D1 | There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D1 provides the information for the consort diagram (Figure 1). Data provided on all enrolled patients (N=624). There is one row per patient. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®